Sean Van Helden

6PUBLICATIONS
15CO-AUTHORS
Medical bacteriologyMajor global burdens of diseaseMedical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 15, 2026
Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers.

|Mar 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving Enterobacterales.

Sean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy

|Dec 05, 2025
Impact of Pseudomonas aeruginosa biofilm exopolysaccharide composition on bacteriophage and bacteriophage-antibiotic combination activity.

Sean R Van Helden, Callan R Bleick, Dana J Holger

|Nov 18, 2025
Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates.

Callan R Bleick, Sean R Van Helden, Andrew D Berti

|Jun 21, 2025
Cefepime-taniborbactam: Ushering in the era of metallo-β-lactamase inhibition.

Sean R Van Helden, Mohammed Al Musawa, Callan R Bleick

|Nov 27, 2024
Aztreonam-avibactam: The dynamic duo against multidrug-resistant gram-negative pathogens.

Mohammed Al Musawa, Callan R Bleick, Shelbye R Herbin

Pageof 1

Frequent Collaborators

6 joint publications

Michael J Rybak

3 joint publications

Callan R Bleick

2 joint publications

Mohammed Al Musawa

2 joint publications

Shelbye R Herbin